13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001792126
申報總市值
US$23.2億
US$23.2億
63 檔
29.6%
Logos Global Management LP 在 Q1 2026 季度的美股部位總計估值為 US$23.2億，分散於 63 個持倉標的之中，反映其市場參與廣度與投資規模。
在 Q1 2026 期間，Logos Global Management LP 展現了靈活的資產再平衡步調，透過出清 15 檔弱勢或達到目標價部位，將資金轉置於 11 檔新建倉標的之中。
在資產配置集中度方面，Logos Global Management LP 的前 5 大核心持股（包含 RVMD, ERAS, IDYA 等）合計佔整體申報市值的 29.6%，反映機構在主要關鍵部位上的權重分佈。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | 股票-醫療保健 | 9.71% | -4.07% | -33.33% | |
| 2 | ERAS | Erasca Inc | 股票-其他 | 9.01% | +0.57% | -14.23% | |
| 3 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 5.74% | -0.93% | -3.50% | |
| 4 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 5.26% | -5.26% | EXIT | |
| 5 | PRAX | Praxis Precision Medicines I | 股票-其他 | 4.58% | -0.83% | -24.00% | |
| 6 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 4.21% | -4.21% | EXIT | |
| 7 | ABVX | Abivax Sa-adr | 股票-其他 | 3.75% | +2.12% | +68.75% | |
| 8 | TNGX | Tango Therapeutics Inc | 股票-其他 | 3.13% | +0.71% | -28.57% | |
| 9 | CYTK | Cytokinetics Inc | 股票-醫療保健 | 2.88% | -2.88% | EXIT | |
| 10 | OLMA | Olema Pharmaceuticals Inc | 股票-其他 | 2.39% | -0.66% | — | |
| 11 | UTHR | United Therapeutics CORP | 股票-醫療保健 | 2.37% | -2.37% | EXIT | |
| 12 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 2.26% | -1.44% | +76.47% | |
| 13 | MDGL | Madrigal Pharmaceuticals Inc | 股票-醫療保健 | 2.22% | -2.22% | EXIT | |
| 14 | ELVN | Enliven Therapeutics Inc | 股票-其他 | 2.04% | -1.02% | +205.88% | |
| 15 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 1.95% | -1.35% | +136.84% | |
| 16 | CGON | Cg Oncology Inc | 股票-其他 | 1.94% | +1.12% | +187.50% | |
| 17 | MAZE | Maze Therapeutics Inc | 股票-其他 | 1.84% | +0.65% | +30.00% | |
| 18 | BIIB | Biogen Inc | 股票-醫療保健 | 1.83% | -1.83% | EXIT | |
| 19 | IRON | Disc Medicine Inc | 股票-其他 | 1.79% | +0.97% | +9.80% | |
| 20 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 1.68% | +1.68% | +26.98% | |
| 21 | OCUL | Ocular Therapeutix Inc | 股票-其他 | 1.63% | +0.61% | +10.00% | |
| 22 | TYRA | Tyra Biosciences Inc | 股票-其他 | 1.63% | -1.63% | EXIT | |
| 23 | TRVI | Trevi Therapeutics Inc | 股票-其他 | 1.43% | +0.08% | +54.84% | |
| 24 | MLTX | Moonlake Immunotherapeutics | 股票-其他 | 1.40% | +0.84% | -14.29% | |
| 25 | IMVT | Immunovant Inc | 股票-其他 | 1.33% | -0.23% | -21.82% | |
| 26 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.31% | -0.14% | — | |
| 27 | RCUS | Arcus Biosciences Inc | 股票-其他 | 1.29% | -0.43% | +14.29% | |
| 28 | DYN | Dyne Therapeutics Inc | 股票-其他 | 1.27% | +1.17% | +12.00% | |
| 29 | GPCR | Structure Therapeutics Inc | 股票-其他 | 1.20% | -0.04% | -16.67% | |
| 30 | LBRX | Lb Pharmaceuticals Inc | 股票-其他 | 1.13% | -0.31% | -23.75% | |
| 31 | DSGN | Design Therapeutics Inc | 股票-其他 | 1.04% | +0.83% | -22.00% | |
| 32 | AVTX | Avalo Therapeutics Inc | 股票-其他 | 0.97% | -0.06% | — | |
| 33 | NERV | Minerva Neurosciences Inc | 股票-其他 | 0.97% | -0.18% | -2.90% | |
| 34 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.96% | -0.96% | EXIT | |
| 35 | MIRM | Mirum Pharmaceuticals Inc | 股票-其他 | 0.92% | -0.92% | EXIT | |
| 36 | PCVX | Vaxcyte Inc | 股票-其他 | 0.87% | -0.87% | EXIT | |
| 37 | ACAD | Acadia Pharmaceuticals Inc | 股票-醫療保健 | 0.83% | -0.56% | -11.76% | |
| 38 | CMPX | Compass Therapeutics Inc | 股票-其他 | 0.83% | -0.83% | EXIT | |
| 39 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 0.71% | +2.65% | +28.57% | |
| 40 | JANX | Janux Therapeutics Inc | 股票-其他 | 0.69% | -0.69% | EXIT | |
| 41 | VOR | Vor Biopharma Inc | 股票-其他 | 0.67% | -0.15% | +650.00% | |
| 42 | ALKS | Alkermes plc | 股票-醫療保健 | 0.62% | -0.62% | EXIT | |
| 43 | ORIC | Oric Pharmaceuticals Inc | 股票-其他 | 0.60% | -0.60% | EXIT | |
| 44 | IMMX | Immix Biopharma Inc | 股票-其他 | 0.56% | -0.12% | +22.50% | |
| 45 | TENX | Tenax Therapeutics Inc | 股票-其他 | 0.50% | -0.31% | — | |
| 46 | AMLX | Amylyx Pharmaceuticals Inc | 股票-其他 | 0.49% | -0.22% | -26.32% | |
| 47 | ✓ | Crescent Biopharma Inc. | 股票-其他 | 0.44% | +1.03% | -19.58% | |
| 48 | SLNOEUR | Soleno Therapeutics Inc | 股票-其他 | 0.42% | -0.42% | EXIT | |
| 49 | AVBP | Arrivent Biopharma Inc | 股票-其他 | 0.40% | +1.10% | — | |
| 50 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.37% | -0.09% | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | ERAS | Erasca Inc | +6.1% | -14.23% | 減碼 |
| 2 | 260 | Centessa Pharmaceuticals-adr | +3.9% | +962.50% | 加碼 |
| 3 | 430 | Terns Pharmaceuticals Inc | +3.4% | +166.67% | 加碼 |
| 4 | CYTK | Cytokinetics Inc | +1.7% | +191.67% | 加碼 |
| 5 | ELVN | Enliven Therapeutics Inc | +1.7% | +205.88% | 加碼 |
| 6 | CGON | Cg Oncology Inc | +1.4% | +187.50% | 加碼 |
| 7 | TYRA | Tyra Biosciences Inc | +1.3% | +304.76% | 加碼 |
| 8 | DNTH | Dianthus Therapeutics Inc | +0.9% | +26.98% | 加碼 |
| 9 | TNGX | Tango Therapeutics Inc | +0.9% | -28.57% | 減碼 |
| 10 | RYTM | Rhythm Pharmaceuticals Inc | +0.7% | +136.84% | 加碼 |
| 11 | VOR | Vor Biopharma Inc | +0.6% | +650.00% | 加碼 |
| 12 | ABVX | Abivax Sa-adr | +0.5% | +68.75% | 加碼 |
| 13 | IMCR | Immunocore Holdings Plc-adr | +0.5% | +76.47% | 加碼 |
| 14 | CMPX | Compass Therapeutics Inc | +0.5% | +173.91% | 加碼 |
| 15 | ORIC | Oric Pharmaceuticals Inc | +0.4% | +111.11% | 加碼 |
| 16 | TRVI | Trevi Therapeutics Inc | +0.3% | +54.84% | 加碼 |
| 17 | IMMX | Immix Biopharma Inc | +0.2% | +22.50% | 加碼 |
| 18 | NERV | Minerva Neurosciences Inc | +0.2% | -2.90% | 減碼 |
| 19 | CLDX | Celldex Therapeutics Inc | +0.1% | +28.57% | 加碼 |
| 20 | CRVS | Corvus Pharmaceuticals Inc | +0.1% | -10.00% | 減碼 |
| 21 | MLTX | Moonlake Immunotherapeutics | 0% | -14.29% | 減碼 |
| 22 | NAMS | NewAmsterdam Pharma Company N.V. | 0% | +33.33% | 加碼 |
| 23 | ✓ | Crescent Biopharma Inc. | 0% | -19.58% | 減碼 |
| 24 | UNCY | Unicycive Therapeutics Inc | 0% | — | 不變 |
| 25 | PTN | Palatin Technologies Inc | 0% | — | 不變 |
| 26 | SEPN | Septerna Inc | 0% | — | 不變 |
| 27 | ACRS | Aclaris Therapeutics Inc | 0% | -16.67% | 減碼 |
| 28 | PHVS | Pharvaris N.V. | -0.1% | -35.00% | 減碼 |
| 29 | JBIO | Jade Biosciences Inc | -0.1% | +1.27% | 加碼 |
| 30 | IBIO | Ibio Inc | -0.1% | -35.00% | 減碼 |
| 31 | GUTS | Fractyl Health Inc | -0.1% | -9.09% | 減碼 |
| 32 | JANX | Janux Therapeutics Inc | -0.1% | — | 不變 |
| 33 | MIRM | Mirum Pharmaceuticals Inc | -0.2% | -11.11% | 減碼 |
| 34 | AMLX | Amylyx Pharmaceuticals Inc | -0.2% | -26.32% | 減碼 |
| 35 | DYN | Dyne Therapeutics Inc | -0.2% | +12.00% | 加碼 |
| 36 | RCUS | Arcus Biosciences Inc | -0.2% | +14.29% | 加碼 |
| 37 | BIIB | Biogen Inc | -0.3% | — | 不變 |
| 38 | DSGN | Design Therapeutics Inc | -0.4% | -22.00% | 減碼 |
| 39 | SLNOEUR | Soleno Therapeutics Inc | -0.4% | -16.67% | 減碼 |
| 40 | LBRX | Lb Pharmaceuticals Inc | -0.5% | -23.75% | 減碼 |
| 41 | VSTM | Verastem Inc | -0.5% | -41.18% | 減碼 |
| 42 | ACAD | Acadia Pharmaceuticals Inc | -0.5% | -11.76% | 減碼 |
| 43 | MAZE | Maze Therapeutics Inc | -0.5% | +30.00% | 加碼 |
| 44 | IRON | Disc Medicine Inc | -0.7% | +9.80% | 加碼 |
| 45 | IMVT | Immunovant Inc | -0.8% | -21.82% | 減碼 |
| 46 | PCVX | Vaxcyte Inc | -0.9% | -53.85% | 減碼 |
| 47 | OCUL | Ocular Therapeutix Inc | -0.9% | +10.00% | 加碼 |
| 48 | GPCR | Structure Therapeutics Inc | -1.3% | -16.67% | 減碼 |
| 49 | IDYA | Ideaya Biosciences Inc | -1.7% | -3.50% | 減碼 |
| 50 | PRAX | Praxis Precision Medicines I | -2.1% | -24.00% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Logos Global Management LP 在 Q1 2026 季度的美股持倉總市值約為 US$23.2億，共申報了 63 個公開持股部位。
在 Q1 2026 季度，Logos Global Management LP 按市值排列的前三大核心持股分別為：RVMD (9.7%)、ERAS (9.0%)、IDYA (5.7%)。其中最大持股部位 RVMD 佔據整體投資組合約 9.7% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
UTHR
市值: US$4743.8萬
本季最大獲利了結 / 清倉標的
CDTX
前期市值: US$6847.6萬
在 Q1 2026 季度中，Logos Global Management LP 共進行了 72 項持倉異動，包含新建倉 11 個部位、加碼 23 個部位、減碼 23 個部位以及清倉 15 個部位。 其中最大新建倉標的為 UTHR。 本季清倉部位包含 CDTX。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。